Literature DB >> 25108699

Astroblastoma: report of two cases with unexpected clinical behavior and review of the literature.

Claudia Janz1, Ralf Buhl2.   

Abstract

Astroblastoma is a rare, mostly supratentorial glial tumor, occurring predominantly in children and young adults with female preponderance. Due to the rarity, with only about 230 reported cases, treatment strategies are still to be discussed. We describe two more cases to add to the clinical experiences with this tumor entity. In both of these cases, the clinical behavior did not follow the expectations based on histopathological classification. Case 1: A sixteen-year old female presented with a six month history of intermittent headaches, nausea and dizziness. MRI scans revealed a left parietooccipital mass lesion with bubbly contrast enhancement and marked peritumoral edema. After gross total tumor resection the histology gave the diagnosis of low grade astroblastoma. Fifteen months later, the patient was operated on a local recurrence and received postoperative radiotherapy, with the histology still being that of low grade astroblastoma. Two years later, a meningeally based tumor nodule frontal of the former tumor bed was removed, now diagnosed as high grade astroblastoma. Eighteen months later, a fourth operation with excision of two more meningeally based tumor nodules of high-grade astroblastoma followed. Chemotherapy was suggested, but the patient decided against it. The last MRI follow-up 14 months after last operation showed no further recurrence so far. Case 2: A 24-year old female presented with a four week history of vomiting and headaches with focal seizures affecting her left arm. CT and MRI scans revealed a superficial partly cystic right temporal mass lesion with few edema and macrocalcifications and adjacent bone atrophy. Despite dural invasion, total tumor resection could be performed. MRI scans six months later showed no recurrence. The patient refused further MRI controls but did not show any clinical signs or symptoms suggesting tumor recurrence four years after the operation. In order to find more predictive tools that might help to determine the individual clinical course and treatment, we performed a review of the literature, analyzing 29 cases with detailed data on clinical history, MRI/CT characteristics, histopathological subtyping, treatment details and a follow-up of at least 12 months. We found, that low-grade astroblastoma with marked peritumoral edema has a tendency to early recurrence and suggest that it should be treated by combined surgery and radiotherapy. In high-grade astroblastoma with well defined tumor borders and few peritumoral edema, the prognosis may be better than expected for a high-grade glioma, if GTR is possible.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bone atrophy; Dural invasion; High-grade astroblastoma; Low-grade astroblastoma; Macrocalcification

Mesh:

Year:  2014        PMID: 25108699     DOI: 10.1016/j.clineuro.2014.07.013

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  14 in total

1.  The use of 5-aminolevulinic acid to assist gross total resection of pediatric astroblastoma.

Authors:  Yuji Agawa; Takafumi Wataya
Journal:  Childs Nerv Syst       Date:  2018-01-05       Impact factor: 1.475

2.  Activation of glioma cells generates immune tolerant NKT cells.

Authors:  Bo Tang; Wei Wu; Xiaowei Wei; Yang Li; Gang Ren; Wenhai Fan
Journal:  J Biol Chem       Date:  2014-10-23       Impact factor: 5.157

3.  Patterns of care and survival outcomes in patients with astroblastoma: an individual patient data analysis of 152 cases.

Authors:  Supriya Mallick; Rony Benson; Bhanuprasad Venkatesulu; Wineeta Melgandi; Goura K Rath
Journal:  Childs Nerv Syst       Date:  2017-05-05       Impact factor: 1.475

4.  Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.

Authors:  Matthew D Wood; Tarik Tihan; Arie Perry; Geeta Chacko; Clinton Turner; Cunfeng Pu; Christopher Payne; Alexander Yu; Serguei I Bannykh; David A Solomon
Journal:  Brain Pathol       Date:  2017-10-27       Impact factor: 6.508

Review 5.  Neuroradiologic characteristics of astroblastoma and systematic review of the literature: 2 new cases and 125 cases reported in 59 publications.

Authors:  Danielle A Cunningham; Lisa H Lowe; Lei Shao; Natasha R Acosta
Journal:  Pediatr Radiol       Date:  2016-04-05

6.  A Pediatric Tumor Found Frequently in the Adult Population: A Case of Anaplastic Astroblastoma in an Elderly Patient and Review of the Literature.

Authors:  Christopher Payne; Ali Batouli; Kristen Stabingas; Dunbar Alcindor; Khaled Abdel Aziz; Cunfeng Pu; Elizabeth Tyler-Kabara; Robert Williams; Alexander Yu
Journal:  Case Rep Neurol Med       Date:  2017-01-23

7.  A case of astroblastoma: Radiological and histopathological characteristics and a review of current treatment options.

Authors:  Derek C Samples; James Henry; Fang Frank Yu; Carlos Bazan; Izabela Tarasiewicz
Journal:  Surg Neurol Int       Date:  2016-12-12

8.  Astroblastoma in a Young Female Patient: A Case Report and Literature Review of Clinicopathological, Radiological and Prognostic Characteristics and Current Treatment Strategies.

Authors:  Muhammad Sadiq; Iftikhar Ahmad; Jamila Shuja; Zubair Ahmad; Riyasat Ahmed; Khushnaseeb Ahmad
Journal:  Brain Tumor Res Treat       Date:  2017-10-31

Review 9.  Astroblastoma - a rare and challenging tumor: a case report and review of the literature.

Authors:  Nawal Hammas; Nadia Senhaji; My Youssef Alaoui Lamrani; Sanae Bennis; Elfaiz Mohamed Chaoui; Hind El Fatemi; Laila Chbani
Journal:  J Med Case Rep       Date:  2018-04-21

10.  The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion.

Authors:  Anna Burford; Alan Mackay; Sergey Popov; Maria Vinci; Diana Carvalho; Matthew Clarke; Elisa Izquierdo; Aimee Avery; Thomas S Jacques; Wendy J Ingram; Andrew S Moore; Kieran Frawley; Timothy E Hassall; Thomas Robertson; Chris Jones
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.